Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) 52 Week High Streak: Second Straight Session Near One-Year Peak
- September 17, 2026
- Posted by: Chaitanya Auti
- Category: News
Aarey Drugs & Pharmaceuticals Ltd. has now traded within 2% of its 52-week high for a second straight session, with the stock up 2.23% across the streak. It traded at Rs 107.6, touched a high of Rs 107.65 and stayed close to the one-year peak through the morning trade. According to latest Univest data, the pattern is confirmed, but it does not establish a company-specific catalyst for the continued move.
The stock had earlier moved into this zone in the prior session, opened at Rs 107.55 and touched a low of Rs 105.4 in the current session. With a market capitalisation of Rs 345.68 crore, Aarey Drugs & Pharmaceuticals Ltd. is drawing attention for the repeated-high pattern itself. That makes this a streak story rather than a one-session update.
Aarey Drugs & Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 107.6 |
| Previous Close | Rs 108.45 |
| Today's Move | Rs -0.85 (-0.78%) |
| Open | Rs 107.55 |
| High | Rs 107.65 |
| Low | Rs 105.4 |
| Market Capitalisation | Rs 345.68 crore |
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) traded at Rs 107.6 versus the previous close of Rs 108.45, a fall of 0.78%. The stock opened at Rs 107.55, reached a high of Rs 107.65 and touched a low of Rs 105.4.
The important point today is not only the rupee move from the prior session, but the fact that Aarey Drugs & Pharmaceuticals Ltd. 52 Week High Streak has remained intact across back-to-back sessions. That repeated placement near the one-year peak is what separates this article from a one-session update. For readers tracking Aarey Drugs & Pharmaceuticals stock analysis, the current price action shows the stock holding near the same zone again while still trading within the event’s 2% band.
What the Repeated 52-Week Highs Show
Aarey Drugs & Pharmaceuticals Ltd. 52 Week High Streak now spans two consecutive sessions, and the cumulative move across that stretch is 2.23%. That is the key read for this event: the stock has not only stayed near its 52-week high, it has done so on back-to-back trading days. In practical terms, this means the current Aarey Drugs & Pharmaceuticals stock news flow is being read through a repeated-high pattern rather than a single isolated print.
For market participants, repeated near-high trading often keeps a name on the screen because it suggests steady interest around a narrow price zone. In this case, the session high of Rs 107.65 and the low of Rs 105.4 show that the stock stayed contained while still hovering close to the event level. Aarey Drugs & Pharmaceuticals Ltd. 52 Week High Streak therefore reflects persistence more than dramatic intraday expansion.
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 345.68 crore |
| P/E Ratio | 82.78x |
| P/B Ratio | 2.03x |
| ROE | 2.81% |
| ROCE | 5.57% |
| EPS | Rs 1.31 |
| Book Value Per Share | Rs 53.35 |
| Dividend Yield | 0% |
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) fundamental metrics show P/E 82.78x, P/B 2.03x, ROE 2.81%, ROCE 5.57%. These figures provide context only and are not a buy or sell signal.
Aarey Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 345.68 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 82.78x, P/B at 2.03x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 2.81% and ROCE of 5.57%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 1.31, book value per share of Rs 53.35, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 13.44x, median ROE of 4.09%, median ROCE of 5.99%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Trading |
| Industry | Trading |
| Benchmark Scope | same industry |
| Company P/E Ratio | 82.78x |
| Benchmark Median P/E | 13.44x |
| Benchmark Average P/E | 67.16x |
| Benchmark P/E Range | 0x to 3,047.85x |
| Company P/B Ratio | 2.03x |
| Benchmark Median P/B | 1.31x |
| Company ROE | 2.81% |
| Benchmark Median ROE | 4.09% |
| Company ROCE | 5.57% |
| Benchmark Median ROCE | 5.99% |
| Company Market Capitalisation | Rs 345.68 crore |
| Benchmark Median Market Cap | Rs 52.61 crore |
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) is classified under sector: Trading and industry: Trading.
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a P/E ratio of 82.78x, which is above the benchmark median of 13.44x, a difference of +515.92%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a ROE of 2.81%, which is below the benchmark median of 4.09%, a difference of -31.3%. Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a ROCE of 5.57%, which is below the benchmark median of 5.99%, a difference of -7.01%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Gretex Industries Ltd. | GRETEX | 343.34 | 233.2 | 6.03 | 4.26 | 3.58 |
| Tejassvi Aaharam Ltd. | TEJASSVI | 354.21 | 0 | 8.07 | 0 | -123.61 |
| Agribio Spirits Ltd. | AGRIBIO | 336.32 | 78.94 | 4.69 | 6.48 | 7.16 |
| DIVINE HIRA JEWELLERS LTD | DIVINEHIRA | 355.6 | 49.91 | 4.58 | 15.17 | 16.15 |
| Starlineps Enterprises Ltd. | STARLENT | 334 | 551.86 | 3.49 | 1.75 | 1.87 |
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a P/E ratio of 82.78x compared with the displayed peer median of 78.94x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 2.81% compares with a peer median of 4.26% across the companies shown in the table. ROCE stood at 5.57% versus the displayed peer median of 3.58%, providing a capital-efficiency comparison. Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a market capitalisation of Rs 345.68 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Aarey Drugs & Pharmaceuticals Ltd.
- The stock is in its second straight session within 2% of the 52-week high.
- The cumulative streak move stands at 2.23% according to latest Univest data.
- Market capitalisation of Rs 345.68 crore keeps the company in focus among smaller names.
- Valuation remains elevated versus the same-industry median P/E.
- The session range stayed narrow near the yearly peak, which traders often monitor closely.
About Aarey Drugs & Pharmaceuticals Ltd.
Aarey Drugs & Pharmaceuticals Ltd. is listed under the symbol AAREYDRUGS and operates within the Trading sector. The company has a market capitalisation of Rs 345.68 crore and is currently trading close to its 52-week high zone. Its latest Univest profile highlights a valuation premium versus the industry median and modest return ratios. For readers following the Aarey Drugs & Pharmaceuticals Ltd. 52 Week High Streak, the company’s size and valuation backdrop provide useful context for the recent price behaviour.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What does the Aarey Drugs & Pharmaceuticals Ltd. 52 Week High Streak mean?
Ans. Aarey Drugs & Pharmaceuticals Ltd. 52 Week High Streak means the stock has traded within 2% of its 52-week high for two consecutive sessions. It highlights persistent trading near the yearly peak rather than a single sharp move.
What was the latest price mentioned for AAREYDRUGS?
Ans. The stock was at Rs 107.6 in the latest update, while the session high reached Rs 107.65. Those levels kept it close to the 52-week high zone through the morning trade.
How much did the stock move across the streak?
Ans. According to latest Univest data, the cumulative move across the two-session streak was 2.23%. That figure describes the combined movement over the streak period, not a one-day swing.
What was the previous close for Aarey Drugs & Pharmaceuticals Ltd.?
Ans. The previous close was Rs 108.45. The current trading level sat slightly below that mark while still remaining inside the narrow band around the yearly high.
What is the market capitalisation of Aarey Drugs & Pharmaceuticals Ltd.?
Ans. The market capitalisation stood at Rs 345.68 crore. That places the company among smaller listed names and helps explain why price moves can attract quick attention from market watchers.
What do the valuation ratios show?
Ans. The stock carried a P/E ratio of 82.78x and a P/B ratio of 2.03x. Those valuation measures should be read alongside sector comparisons and the company’s return ratios.
How do the return ratios compare with the industry?
Ans. ROE stood at 2.81% and ROCE at 5.57%. The latest Univest same-industry benchmark shows these levels below the median ROE and slightly below the median ROCE. The relevant peer median ROE is 4.09%.
Why is this article focused on a streak instead of a single session?
Ans. This article tracks the repeated near-high pattern because the stock has stayed within 2% of its 52-week high for a second straight session. That makes the move more about persistence than a one-off price spike.
Track Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) Share Price on Univest
Use Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.